- Reumelox is a drug with analgesic and anti-inflammatory. The active substance is meloxicam, which belongs to a class of non-steroidal anti-inflammatory drugs. Reumelox is indicated for the symptomatic treatment of bone and joint pain.
The active substance in one tablet Reumelox: meloxicam - 7.5 mg. Excipients: corn starch, pregelatinised maize starch, colloidal silica, sodium citrate, lactose monohydrate, microcrystalline cellulose, magnesium stearate.
drug Reumelox with analgesic and anti-inflammatory. Reumelox is responsible for the efficacy of meloxicam. This is a non-steroidal anti-inflammatory drug, enol ester derivative. Meloxicam is a preferential inhibitor of inducible cyclooxygenase (COX-2), which is responsible for the synthesis of pro-inflammatory prostaglandins.
The drug Reumelox intended for short-term use in the symptomatic management of acute pain, osteo-articular diseases and muscle degenerative rheumatoid arthritis. It can be used as a continuation of your doctor after a diagnosis of osteoarthritis, rheumatoid arthritis or ankylosing spondylitis.
Reumelox Additional information:
The product stored at room temperature, below 25st. C, out of reach of children. Protect from light and moisture.
not be used in case of hypersensitivity to the active substance (and other non-steroidal anti-inflammatory drugs including aspirin) and other ingredients. Do not use if the patient has or have a history of allergy symptoms as asthma (wheezing), nasal polyps (nasal congestion due to mucosal edema) accompanied by rhinitis, angioedema or urticaria associated with aspirin or non-steroidal anti-inflammatory drugs; patients with active, or recurrent ulcers of the stomach and / or duodenum; in patients with perforation or gastrointestinal bleeding associated with the treatment of other non-steroidal anti-inflammatory drugs; in patients with other bleeding or gastrointestinal bleeding (bleeding from the stomach or intestines), cerebral bleeding; patients with severe renal impairment; in patients with severe renal impairment, in patients not on dialysis; in patients with severe heart failure; in children and adolescents below 16 years of age; in patients during pregnancy and lactation.
Reumelox Adverse reactions:
While taking side effects may occur, in which case it is necessary to immediately discontinue use: gastrointestinal bleeding (bloody stools or vomiting); onset of dyspnoea (difficulty in breathing); swelling of the face; swelling of the mouth, and (or) the throat manifesting the occurrence of difficulty in swallowing or breathing; rash or mucous membrane lesions.
They are also common: dizziness, headache, indigestion, nausea and vomiting, abdominal pain, constipation, bloating, diarrhea. Uncommon: anemia (low red blood cell count), dizziness, drowsiness, increased blood pressure, flushing, gastrointestinal bleeding, peptic ulcers, esophagitis, inflammation of the oral mucosa (including ulcerative), transient abnormal liver function (eg. increased transaminases and bilirubin), urticaria, pruritus, rash, retention of sodium and water, hyperkalemia, impaired renal function indices (eg. elevated creatinine or urea).
Use as directed on the package leaflet or as prescribed by the doctor or pharmacist. Consult with your doctor the use of the drug for the first time. For oral use. Taken once daily with food, drinking water or other liquid. Adults: The recommended dose is one tablet daily, ie 7.5 mg meloxicam.
Dose not exceed 15 mg (2 tablets) per day. Without consulting a doctor drug can be used up to 7 days. The elderly who are at higher risk of side effects: the recommended daily dose - 7.5 mg. Patients with renal failure - can not take doses greater than 7.5 mg daily. In patients with mild or moderate renal impairment does not need to be reduced.